MannKind Corp
(NAS:MNKD)
$
6.61
-0.06 (-0.9%)
Market Cap: 1.84 Bil
Enterprise Value: 1.83 Bil
PE Ratio: 83.38
PB Ratio: 0
GF Score: 74/100 MannKind Corp at Cantor Fitzgerald Global Healthcare Conference Transcript
Sep 27, 2023 / 03:30PM GMT
Release Date Price:
$4.1
(+1.74%)
Olivia Bryer
Cantor Fitzgerald - Analyst
Welcome to day two of our Cantor Healthcare Conference. Really excited to be back in person with everyone this year. My name is Olivia Bryer, I'm a senior biotech analyst here at Cantor. And really excited to have our guest speaker with us here today. We've got CEO of MannKind, Michael Castagna. Michael, thanks so much for joining us today.
Michael Castagna
MannKind Corporation - CEO
Thank you.
Olivia Bryer
Cantor Fitzgerald - Analyst
Yeah. Great to see you.
Michael Castagna
MannKind Corporation - CEO
Thanks for having us.
Questions & Answers
Olivia Bryer
Cantor Fitzgerald - Analyst
Michael, I'm sure most of the room is familiar with the story, and you guys obviously have a lot going on. I think the story is going through a significant transition right now with the company. So maybe just to kick things off, set the stage with where the company is today, some of the
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot